Kobayashi Pharmaceutical， which is in turmoil over its red yeast rice product， has finally released an investigation report． Here are three problems that can be seen from the delayed response．
0001@Old Man Friends Club ★ Security Guard [lv.7] [Sprout].Aug. 29, 2024 (Thu) 12:25:50.52ID:Np37grcO9
Kobayashi Pharmaceutical, which has been in a major scandal over deaths caused by its red koji-related products, has finally released an investigation report. This time, we will use the report to highlight the company’s problems. Kobayashi Pharmaceutical has been in the spotlight after a number of people lost their lives after consuming functional foods made with red koji that the company produced. A fact-finding committee made up of external experts has compiled an investigation report and made it public at the company’s financial results announcement press conference. The circumstances surrounding the accident and the reasons for the delay in reporting the injuries to the authorities and in recalling the products were also made clear. Not only have the various problems the company faces been brought to light once again, but it now finds itself in a situation where it has no choice but to carry out a fundamental restructuring of its management. I think there are three main issues. The first issue is whether Kobayashi Pharmaceutical is truly qualified to handle products that contribute to maintaining the health of users, including its basic corporate stance. The second issue was governance, in that important checks on management, including those by auditors and outside directors, were not functioning properly. The third issue is the disadvantages of family-run businesses and the lack of awareness and response to them. Let’s start with the first problem. It is believed that the red koji-related functional foods that have caused many deaths are most likely caused by “puvelluric acid” derived from blue mold that was somehow mixed in during the manufacturing process. The Ministry of Health, Labor and Welfare believes that blue mold within the factory was mixed in at the Red Aspergillus fungus cultivation stage, producing three unexpected compounds, including puvelic acid. The fundamental issue is whether it is acceptable for a factory that handles health-related foods to have an environment that allows the growth of blue mold. The red koji was cultivated at the company’s Osaka factory, a well-established facility that began operations in 1940 and has been in operation for over 80 years. Continued on itmedia Business Online 2024/08/29.
>>1 > The basic issue is whether it is acceptable for a factory that handles health-related foods to have an environment that allows blue mold to grow. > The red koji was cultivated at the company’s Osaka factory, a well-established site that began operations in 1940 and has been in operation for over 80 years. Most of the food industry in Japan is at this level. They even show things like inviting dirt into their factories on TV, even big companies do it. And the wages aren’t high enough to hire enough workers to do the job properly.
Only low-ranking public universities use the misleading term “national and public universities”! ★2 Be careful, public universities are private universities run by some local government ★4.
>>10 Isn’t there a company that doesn’t do insider trading? Usually, before a scandal is made public, the stock price plummets along with the trading volume. Adults are dirty.
They made red koji using moldy manufacturing equipment, and the factory that caused serious health damage was closed down before the damage came to light, leaving the land vacant. They call themselves a pharmaceutical company, but they’re a shady company.
A country that is shifting the blame for vaccine damage to koji and is trying to destroy a traditional Japanese food that has vaccine detoxifying properties.
Those who worked there may see the company trying to recover, but from the outside it looks like a company that has definitely gone bankrupt. No wonder the investigation report is delayed.
After discovering the antiviral effects of iodine against the coronavirus, the company was shut down, its stock price was lowered, and a certain number of shares were stolen by foreign investors.
With social credibility declining, it may be time to close the company. They could sell their oral care business to Sunstar, which is also part of the Sanwa Group, and sell health foods such as Umetan to Morishita Jintan, and toiletry products to Dainippon Jochugiku.
Most of the victims in this case are elderly people, and since elderly people take various medications and supplements at the same time, it’s impossible to know the true extent of the problem. There’s also the theory that it’s just a matter of lifespan. Also, it was discovered that out of the 300 or so people who were picked up as victims, only 70 had actually taken the supplements, so it seems like some big power is behind the scenes.
>>55 It would be a problem if someone with some kind of physical condition used it and it had an adverse effect. There are no medical examinations or checks like there are with prescription drugs.
>>55 Takeover According to a large-scale shareholding report submitted to the Kanto Regional Financial Bureau by Hong Kong investment fund Oasis Management on the 24th, it has acquired 5.2% of Kobayashi Pharmaceutical’s issued shares. The purpose of acquiring the shares is stated as “portfolio investment and important proposal making.” Oasis is known as an activist fund that actively makes shareholder proposals to domestic listed companies in which it has acquired shares, such as calling for management reviews and the appointment of directors of its own choice.
Comments